BioPharma Pharma Research

OSF HealthCare and Bradley University formalize partnership to solve pressing health care problems

Designed to create a robust, collaborative research community, the new agreement is between employees at two of Peoria's largest and most impactf...

 October 31, 2022 | News

Ardigen supports JUMP-CP Consortium to transform drug discovery with Cell Painting technology

The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cel...

 October 28, 2022 | News

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

 October 26, 2022 | News

Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments

Data demonstrate diversity of vaccine and anti-infective portfolio and cutting-edge scientific approach to battling viral and bacterial infections P...

 October 19, 2022 | News

The Grand Hamdan Award goes to two scientists in Australia

According to an official announcement made recently in Dubai, Prof. Ian Hector Frazer and the Late Dr. Jian Zhou are the winners o...

 October 19, 2022 | News

Kira Pharmaceuticals Announces IND Approval from Chinese NMPA

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today th...

 October 17, 2022 | News

Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

Menarini Silicon Biosystems (MSB), Inc. is announcing that the AMA has issued Current Procedural Terminology (CPT®) Proprietary Laboratory Analyse...

 October 14, 2022 | News

New cell population identified in Alzheimer's Disease allows better targeting of macrophage populations in treatment of neurodegeneration

An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...

 October 11, 2022 | News

Cytiva strengthens cell line development with CEVEC acquisition

Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, G...

 October 06, 2022 | News

Astellas and Pantherna Enter into a New Technology Evaluation Agreement

Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pantherna Therapeutics GmbH (CEO:Klaus Giese, Ph.D., "Panthe...

 October 04, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

 September 27, 2022 | News

Sciwind Biosciences and SynerK Enter into Research Partnership

The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA deliv...

 September 27, 2022 | News

AAHRPP Accredits Five More Research Organizations, Including First in Japan

At its September meeting, AAHRPP's Council on Accreditation awarded full accreditation to: Adventist Health Glendale, Glendale, California, a hospi...

 September 26, 2022 | News

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

With the support of the Singapore Economic Development Board (EDB), the hub comprises a pilot manufacturing facility and an R&D centre. SCG expect...

 September 21, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close